Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 27, 2016 - Issue 6
Submit an article Journal homepage
232
Views
9
CrossRef citations to date
0
Altmetric
Oncology

Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study

Francesco RicciInstitute of Dermatology, Catholic University of the Sacred Heart, Rome, Italy;
,
Sara TamboneDepartment of Dermatology, University of L’Aquila, L’Aquila Italy;
,
Luca NeriOutcomes Research Consulting, Milano, Italy
,
Luca FaniaInstitute of Dermatology, Catholic University of the Sacred Heart, Rome, Italy;
,
Antonella PiccioniDepartment of Dermatology, University of L’Aquila, L’Aquila Italy;
,
Cristina GuerrieroInstitute of Dermatology, Catholic University of the Sacred Heart, Rome, Italy;
,
Maria Concetta FargnoliDepartment of Dermatology, University of L’Aquila, L’Aquila Italy;
&
Ketty PerisInstitute of Dermatology, Catholic University of the Sacred Heart, Rome, Italy; Correspondence[email protected]
 show all
Pages 525-530 | Received 01 Feb 2016, Accepted 28 Feb 2016, Published online: 04 Apr 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Lutz Schmitz, Jes B. Hansen, Mike Bastian, Thomas Larsson & Eggert Stockfleth. (2021) Treatment responder analysis in actinic keratosis: can it lead the way to individualized choice of treatment?. Journal of Dermatological Treatment 32:4, pages 411-417.
Read now
Nevena Skroza, Nicoletta Bernardini, Ilaria Proietti & Concetta Potenza. (2018) Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice. Therapeutics and Clinical Risk Management 14, pages 1879-1885.
Read now
Rosa Ortega del Olmo & Rafael Salido-Vallejo. (2018) Ingenol mebutate for the treatment of actinic keratosis: effectiveness and safety in 246 patients treated in real-life clinical practice. Journal of Dermatological Treatment 29:4, pages 393-399.
Read now
Thomas Dirschka, Girish Gupta, Giuseppe Micali, Eggert Stockfleth, Nicole Basset-Séguin, Véronique Del Marmol, Reinhard Dummer, Gregor B. E. Jemec, Josep Malvehy, Ketty Peris, Susana Puig, Alexander J. Stratigos, Iris Zalaudek & Giovanni Pellacani. (2017) Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology. Journal of Dermatological Treatment 28:5, pages 431-442.
Read now

Articles from other publishers (5)

Robert Sinclair, Christopher Baker, Lynda Spelman, Madeleine Supranowicz & Beth MacMahon. (2020) A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies. Australasian Journal of Dermatology 62:2, pages 119-123.
Crossref
Eftychia Platsidaki, Nikolaos Kostopoulos, Pantelis Panagakis, George Cheliotis, Christina Antoniou & Georgios Kontochristopoulos. (2020) The use of ingenol mebutate to treat actinic keratosis in standard clinical practice: a prospective phase IV multicenter observational cohort study. International Journal of Dermatology 59:6, pages 690-697.
Crossref
Luiz Gameiro, Luis Fernando Requejo Tovo, José Antonio Sanches Júnior & Ivan Aprahamian. (2019) Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives. Anais Brasileiros de Dermatologia 94:3, pages 313-319.
Crossref
Alise Balcere, Māra Rone Kupfere, Ingrīda Čēma & Angelika Krūmiņa. (2019) Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp. Medicina 55:4, pages 92.
Crossref
Marc Z. HandlerBradley S. BloomDavid J. Goldberg. (2018) Clinical and Histologic Evaluation of Ingenol Mebutate 0.015% Gel for the Cosmetic Improvement of Photoaged Skin. Dermatologic Surgery 44:1, pages 61-67.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.